CDKAL1 rs10116277: What Your Genotype Means
The rs10116277 variant is a common genetic marker located within the CDKAL1 gene. It is widely recognized in scientific literature for its statistical association with an increased risk of type 2 diabetes and variations in insulin secretion.
What each genotype means
Lower diabetes risk
This genotype is associated with a lower statistical risk of developing type 2 diabetes compared to carriers of the G allele. Research suggests this variant influences insulin secretion, and individuals with this genotype typically show better insulin response profiles in clinical studies. This is a statistical association and not a medical diagnosis; maintain a healthy lifestyle and discuss any metabolic concerns with your healthcare provider.
The frequency of this genotype varies significantly by ancestry, being more common in populations of East Asian descent compared to those of European ancestry.
Intermediate diabetes risk
This genotype represents an intermediate state regarding the statistical risk of type 2 diabetes associated with the CDKAL1 gene. Studies indicate that carrying one copy of the risk-associated allele may correlate with slightly reduced insulin secretion compared to non-carriers. This is a statistical observation across populations; please consult your physician for personalized health screenings or metabolic assessments.
This is a common genotype found across many global populations, with prevalence rates influenced by regional genetic background.
Increased diabetes risk
This genotype is identified in research as a risk-conferring marker for type 2 diabetes, often associated with impaired insulin secretion from pancreatic beta-cells. While this variant is a well-replicated genetic marker for diabetes susceptibility, it does not guarantee the development of the condition. Focus on proactive health management and discuss your metabolic health with a clinician.
This genotype is highly prevalent in populations of European ancestry and is a well-documented risk factor in global genetic studies.
Understanding the Variant
The rs10116277 variant is a single nucleotide polymorphism (SNP) located within the CDKAL1 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is situated in an intronic region of the gene, meaning it does not code for a protein directly but may influence how the gene is regulated or expressed. Genome-wide association studies (GWAS) have consistently identified this locus as a significant marker for metabolic health. Because it is a common variant, it is found frequently across many human populations, making it a subject of extensive research regarding how genetic architecture contributes to complex, polygenic conditions like type 2 diabetes.
The Role of the CDKAL1 Gene
The CDKAL1 gene, which stands for CDK5 regulatory subunit-associated protein 1-like 1, encodes a protein that functions as a methylthiotransferase. While the full scope of its biological activity is still being explored, research indicates that CDKAL1 plays a critical role in the function of pancreatic beta-cells. These cells are responsible for producing and secreting insulin, the hormone that regulates blood glucose levels. Studies suggest that the protein encoded by CDKAL1 is necessary for proper mitochondrial function and protein translation within these cells. When this gene's function is altered, it may impair the ability of beta-cells to release insulin effectively in response to rising blood sugar, which is a hallmark of type 2 diabetes development.
Research and Statistical Associations
Scientific research has established a strong statistical link between variants in the CDKAL1 gene and type 2 diabetes. Large-scale studies have observed that individuals carrying certain alleles at this locus show a reduced insulin response compared to those who do not. Specifically, research has noted that homozygous carriers of risk-associated alleles may exhibit approximately 20% lower insulin secretion capacity. It is important to note that these findings are based on population-level statistics, which describe trends across large groups rather than predicting the health outcome of any single individual. The strength of this association can vary significantly depending on ancestry, and in some populations, such as African Americans, the association observed in European or East Asian cohorts has not been consistently replicated.
Interpreting Your Information
Genetic information regarding variants like rs10116277 provides insight into biological predispositions, but it is not a diagnostic tool. Having a specific genotype does not mean an individual will develop type 2 diabetes, nor does the absence of a risk allele guarantee protection. Diabetes is a complex condition influenced by a combination of genetic factors, lifestyle choices, diet, and physical activity. If you have received genetic testing results, it is best to view them as one piece of a much larger health puzzle. You cannot use this information to diagnose yourself or to make changes to medical treatments. Always consult with a healthcare professional or a registered dietitian to discuss your overall metabolic health and to create a personalized wellness plan based on your clinical history.
How common is this variant?
The rs10116277 variant is considered a common SNP, with its allele frequencies varying across different global populations. It is frequently studied in European and East Asian cohorts, where its association with metabolic traits is well-documented.
Frequently asked questions
Does having the CDKAL1 risk variant mean I will get diabetes?
No, having a risk variant does not mean you will develop diabetes. Type 2 diabetes is a complex condition influenced by many genes, as well as diet, exercise, and other environmental factors.
Can I use this genetic information to change my medication?
You should never change your medication based on genetic test results. Always discuss your medications and any concerns about your health with your doctor or pharmacist.
Is the CDKAL1 variant associated with other health conditions?
While primarily studied in the context of type 2 diabetes and insulin secretion, some research has explored its potential links to obesity and other metabolic traits. However, the strongest evidence remains its association with pancreatic beta-cell function.
Why do some studies show different results for this gene?
Genetic associations can vary between populations due to differences in genetic background and environmental factors. What is observed in one ethnic group may not be replicated in another, which is a common occurrence in complex disease research.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10116277?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKAL1
Intronic regulatory variant linked to fasting insulin levels and insulin secretion.
Associated with impaired insulin secretion and increased risk of type 2 diabetes; recent evidence suggests sex-specific effects on glycemic control.
This SNP in the CDKAL1 gene is linked to impaired insulin secretion and increased susceptibility to type 2 diabetes.